OM336 in Autoimmune Cytopenias
OM336 in Autoimmune Cytopenias
Recruiting · NCT07083960 · Registry updated 2026-09-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| OM336 in Autoimmune Cytopenias | Cytopenia, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Purpura, Thrombocytopenic, Idiopathic, Signs and Symptoms, Skin Manifestations, anemia, autoimmune disease, autoimmune hemolytic anemia, blood coagulation disease, blood platelet disease, hematologic disorder, hemolytic anemia, hemorrhagic disease, immune system disorder, purpura, thrombocytopenia, thrombocytopenic purpura, thrombotic microangiopathy | Recruiting | Phase 1 | 2026-09-03 | NCT07083960 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Lakefront Biotherapeutics West LLC | 3 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| City of Hope | Duarte | United States | 238 |
| Fred Hutchinson Cancer Center | Seattle | United States | 250 |
| Icon Cancer Center South Brisbane | Brisbane | Australia | 1 |
| Liverpool Hospital | Sydney | Australia | 1 |
| Medstar | Washington D.C. | United States | 1 |
| The Canberra Hospital | Canberra | Australia | 2 |
| University of Michigan | Ann Arbor | United States | 538 |